Streetbeat News

Price Targets

PHVS

Oppenheimer analyst Justin Kim has maintained an 'Outperform' rating on Pharvaris (NASDAQ:PHVS) and raised the price target from $38 to $42.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 12:14 pm

GWRE

Guidewire Software shares rose following strong Q4 results and positive analyst ratings. Oppenheimer and Baird maintained an Outperform rating and increased their price targets for the stock.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 12:13 pm

LYV

Oppenheimer analyst Jed Kelly maintains an Outperform rating on Live Nation Entertainment and raises the price target from $110 to $120.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 12:12 pm

AROC

JP Morgan has initiated coverage on Archrock (NYSE:AROC) with an Overweight rating and set a price target of $24.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 12:12 pm

DPZ

Oppenheimer analyst Brian Bittner maintains an Outperform rating on Domino's Pizza (NYSE:DPZ) but lowers the price target from $510 to $490.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 12:11 pm

AMRX

JP Morgan has upgraded Amneal Pharmaceuticals from Underweight to Neutral, setting a price target of $9.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 12:10 pm

SEM

Benchmark analyst Bill Sutherland has reiterated a Buy rating for Select Medical Holdings (NYSE:SEM) and maintained a price target of $48.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 12:07 pm

NIO

JP Morgan analyst Nick Lai has upgraded NIO from Neutral to Overweight and increased the price target from $5.3 to $8, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 12:06 pm

FOLD

Jefferies has initiated coverage on Amicus Therapeutics with a Buy rating and set a price target of $18.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 12:05 pm

BE

Jefferies analyst Lloyd Byrne has downgraded Bloom Energy from Buy to Hold and reduced the price target from $15 to $11.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 12:03 pm